Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biostate AI Builds Global RNA-AI Pipeline With $12M Boost, Ventures In China And India
Patented Wet-Lab Technologies Can Slash RNA-Seq Costs To Under $20 Per Sample
Jul 31 2025
•
By
Shubham Singh
Bayosthiti, Biostate AI's Indian subsidiary, focuses on developing precision cancer diagnostics specifically tailored to the Indian population. Picture Courtesy: Biostate AI
More from Diagnostics
More from Device Area